| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 5,376,973 | 5,348,319 | 5,829,582 | 5,945,358 | | Cost of Revenue | 1,380,891 | 1,430,350 | 1,571,467 | 1,683,937 | | | Gross Profit | 3,996,082 | 3,917,969 | 4,258,115 | 4,261,421 | | | Operating Expenses | | Research Development | 773,120 | 898,012 | 799,757 | 836,067 | | Selling General and Administrative | 1,591,809 | 1,647,927 | 1,635,719 | 1,832,500 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,631,153 | 1,372,030 | 1,822,639 | 1,592,854 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 122,611 | 439,024 | (110,649) | 25,992 | | Earnings Before Interest And Taxes | 1,753,764 | 1,811,054 | 1,711,990 | 1,618,846 | | Interest Expense | 65,312 | 557,608 | 4,182 |
-
| | Income Before Tax | 1,688,452 | 1,253,446 | 1,707,808 | 1,618,846 | | Income Tax Expense | 490,292 | 293,061 | 569,401 | 496,752 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,198,160 | 960,385 | 1,138,407 | 1,122,094 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,198,160 | 960,385 | 1,138,407 | 1,122,094 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,198,160 | $960,385 | $1,138,407 | $1,122,094 |
|
0.45% Nasdaq 
0.20%
Income Statement
